Replies to post #141386 on Biotech Values

[DewDiligence]

Dalcetrapib’s failure is a pretty big story, IMO. I’m surprised that MRK (anacetrapib—#msg-56794936) and LLY (evacetrapib—#msg-69029766) are not down more on this news.

BMY (#msg-69908574) and RDY (#msg-66767725) are also players in the CETP arena.